Trial ID or NCT#

NCT02224755

Status

RECRUITING

Purpose

The HM3 LVAS is intended to provide hemodynamic support in patients with advanced, refractory left ventricular heart failure; either for short-term support, such as a bridge-to-cardiac transplantation (BTT) or myocardial recovery, or as long-term support, such as destination therapy (DT). The HM3 is intended for use inside or outside the hospital.

Investigator(s)

Joseph Woo, MD

Contact us to find out if this trial is right for you.

CONTACT

Joseph Woo, MD
joswoo@stanford.edu